Methodological proposal to explore and design future health innovation policies and opportunities for Responsible Research and Innovation (RRI)
Arguello, A.; Ortega-Rodriguez, A.; Alvarez, P.
Show abstract
Responsible Research and Innovation (RRI) seeks to align the research results with the needs of society to respond to current and future problems, also encompassing financial instruments, innovative public policies, and the distribution of resources. These policies should prioritize research in those areas with the greatest impact on society, and particularly in health research, this impact should be focused on responding to clinical problems of the population rather than economic impact. A methodology is proposed that uses information from open sources to identify discrepancies between the results of the most translational research of a region and its health needs, in order to provide useful information for the formulation of innovation policies.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- REPLICCAR II Study: Data Quality Audit in the Paulista Cardiovascular Surgery Registry 93%
- Development and validation of a clinical risk score to predict the risk of SARS-CoV-2 infection from administrative data: a population-based cohort study from Italy 92%
- Mapping the coevolution, leadership and financing of research on viral vectors, RNAi, CRSPR/Cas9 and other genomic editing technologies 92%
Similar papers in this journal
- Cohort Study Protocol of the Brazilian Collaborative Research Network on COVID-19: strengthening WHO global data 93%
- Sunshine on KOL : a retrospective study about financial ties between medical key opinion leaders and pharmaceutical industry in France 91%
- Reporting of Retrospective Registration in Clinical Trial Publications 91%
Similar papers in this journal
Similar papers in this journal
- biobank.cy: The Biobank of Cyprus past, present and future 92%
- Differential features of the fifth wave of COVID-19 associated with vaccination and the Delta variant in a reference hospital in Catalonia, Spain 92%
- Real world evidence of calcifediol use and mortality rate of COVID-19 hospitalized in a large cohort of 16,401 Andalusian patients 91%
Similar papers in this journal
- SARS-CoV-2 Infection Breakthrough among the non-vaccinated and vaccinated: a Real World Evidence study based on Big Data 92%
- Beyond vaccination: A Cross-Sectional Study of the importance of Behavioral and Native Factors on COVID-19 Infection and Severity. 89%
- Analysis of daily reproduction rates of COVID-19 using Current Health Expenditure as Gross Domestic Product percentage (CHE/GDP) across countries 88%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.